External preparation containing rapamycin
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- NOBELPHARMA CO LTD
- Publication Date
- 2022-06-03
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to an external preparation containing rapamycin. Specifically, it relates to an external preparation containing rapamycin, excellent in stability, and effective for the treatment of skin diseases. Background technique
[0002] Rapamycin (common name: sirolimus) is a macrolide produced by microorganisms. Rapamycin has an immunosuppressive effect, and thus has been used as a therapeutic drug for various diseases so far. For example, in addition to being used as an internal medicine for the treatment of lymphangioleiomyomatosis, in recent years, it is also used as an external preparation for the treatment of skin lesions accompanying tuberous sclerosis complex.
[0003] On the other hand, although rapamycin is soluble in some organic solvents including ethanol, it is hardly soluble in or hardly soluble in many solvents including water.
[0004] When using rapamycin as an external preparation, it is necessary to dissolve it...